"This is a cannabis stock" -- not a medical marijuana stock, he argued. He said GW Pharma is "a real company" that has other business segments, while also having operations in the medical marijuana field.
"I am shocked at this" bold and timely analyst action, Cramer concluded, calling GW Pharma his favorite cannabis stock.
-- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts